Subject Description
Rapid control of a massive hemorrhage is vitally important to patient survival. Fibrinogen rapidly depletes in bleeding patients and is an independent indicator for severe hemorrhage. Early fibrinogen replacement in bleeding patients may improve patient outcomes. This course will review key clinical trials and the treatment options available for the replacement of fibrinogen in bleeding patients.
Learning Objectives
- Learn about the advancement of hemorrhage control and the MTP
- Discuss the importance of fibrinogen and what makes a healthy clot
- Assess early replacement of fibrinogen in bleeding patients
- Differentiate Cryoprecipitate AHF, Fibrinogen Concentrates, and Pathogen Reduced Cryoprecipitate Fibrinogen Complex
- Analyze studies focusing on cryoprecipitate use and fibrinogen replacement
Level of Instruction
Intermediate
Author / Speaker
Additional Information
Cerus Corporation is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
P.A.C.E.: 368-063-22
Contact Hour: 1.0
Expires on: Jun 25, 2024 at 11:59 pm CT
This program is approved by the California Board of Registered Nursing, Provider Number CEP15148 for 1.0 contact hours
CBRN: 127
Contact Hour: 1.0
Expires at: Jun 25, 2023 at 12:00 am CT
Technical Requirements and Assistance
Minimum software requirements:
-
Operating system
- • Windows XP SP2
- • Mac OS X 10.9
- • iOS 7
- • Android 4
- Web browser
-
Browser plug-ins
- • Learning activities may be encoded as MP4 videos. Your browser must support MP4 playback natively or through the operating system to view these videos.
Minimum hardware requirements:
-
Desktops, laptops
- • 512MB of RAM
- • 200MB of hard drive space
- • Intel x86 processor
-
Mobile devices
- • Device capable of running iOS 7
- • Device capable of running Android 4
Minimum connection speed:
- A broadband connection is required for MP4 learning activities.
Questions or Comments
Please contact support@transfusionsafetyonline.com.